AR032185A1 - Complejos de cis-platino, utiles como agentes antitumorales, y las composiciones farmaceuticas que los contienen - Google Patents
Complejos de cis-platino, utiles como agentes antitumorales, y las composiciones farmaceuticas que los contienenInfo
- Publication number
- AR032185A1 AR032185A1 ARP010104672A ARP010104672A AR032185A1 AR 032185 A1 AR032185 A1 AR 032185A1 AR P010104672 A ARP010104672 A AR P010104672A AR P010104672 A ARP010104672 A AR P010104672A AR 032185 A1 AR032185 A1 AR 032185A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- functional group
- complexes
- platino
- Prior art date
Links
- 239000002246 antineoplastic agent Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 125000000524 functional group Chemical group 0.000 abstract 3
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 abstract 3
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 150000003057 platinum Chemical class 0.000 abstract 2
- 229910052697 platinum Inorganic materials 0.000 abstract 2
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical group NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 abstract 1
- 150000001450 anions Chemical class 0.000 abstract 1
- 229940041181 antineoplastic drug Drugs 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 abstract 1
- -1 carbonate ester Chemical group 0.000 abstract 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical group OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0086—Platinum compounds
- C07F15/0093—Platinum compounds without a metal-carbon linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Fármacos antitumorales de platino, en particular, complejos de platino que poseen la formula (1) o (2) y sus sales aceptables desde el punto de vista farmacéutico, en los cuales, cada A es independientemente un anion; cada B es independientemente halo, hidroxi, carboxilato, carbamato o éster carbonato; Z es un grupo funcional heterocíclico sustituido de 5- o 6- miembros en el cual, el grupo funcional sustituido además comprende un sustituyente que impide estéricamente el acceso del átomo de Pt a una cadena de ADN de una célula tumoral mediante un nivel mensurable más que un grupo funcional heterocíclico no sustituido con la misma estructura cuando se evalua en las mismas condiciones, y donde Z es otro que piridina; y X es NH3, o bien, NH3 sustituido por mono- o dialquilo. También se describen las composiciones farmacéuticas que contienen dichos complejos de platino.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/678,595 US6894049B1 (en) | 2000-10-04 | 2000-10-04 | Platinum complexes as antitumor agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR032185A1 true AR032185A1 (es) | 2003-10-29 |
Family
ID=24723449
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP010104672A AR032185A1 (es) | 2000-10-04 | 2001-10-03 | Complejos de cis-platino, utiles como agentes antitumorales, y las composiciones farmaceuticas que los contienen |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6894049B1 (es) |
| EP (1) | EP1322654B1 (es) |
| JP (1) | JP2004510778A (es) |
| KR (1) | KR100864596B1 (es) |
| AR (1) | AR032185A1 (es) |
| AT (1) | ATE417855T1 (es) |
| AU (1) | AU2001294969A1 (es) |
| DE (1) | DE60137061D1 (es) |
| DK (1) | DK1322654T3 (es) |
| ES (1) | ES2319258T3 (es) |
| PT (1) | PT1322654E (es) |
| SI (1) | SI1322654T1 (es) |
| WO (1) | WO2002028871A1 (es) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0011903D0 (en) * | 2000-05-18 | 2000-07-05 | Astrazeneca Ab | Combination chemotherapy |
| US20080058411A1 (en) | 2004-02-18 | 2008-03-06 | Gpc Biotech Ag | Methods For Treating Resistant Or Refractory Tumors |
| CZ2004964A3 (cs) * | 2004-09-14 | 2006-03-15 | Pliva-Lachema A. S. | Perorální farmaceutická kompozice pro cílený transport komplexu platiny do kolorektální oblasti, zpusob její prípravy a tato kompozice pro pouzití jako lécivo |
| CN101495459A (zh) * | 2005-06-30 | 2009-07-29 | 比奥纽默里克药物公司 | 单吡咯配体铂类似物 |
| EP1896490B1 (en) * | 2005-06-30 | 2013-03-06 | Bionumerik Pharmaceuticals, Inc. | Monoimine ligand platinum analogs |
| WO2007021852A2 (en) * | 2005-08-11 | 2007-02-22 | Virginia Commonwealth University | Transplatinum complexes with n2o2 donor sets as cytotoxic and antitumor agents |
| US8178564B2 (en) * | 2006-11-06 | 2012-05-15 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
| US8173686B2 (en) | 2006-11-06 | 2012-05-08 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
| US8168662B1 (en) | 2006-11-06 | 2012-05-01 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
| US8168661B2 (en) * | 2006-11-06 | 2012-05-01 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
| US20110033528A1 (en) * | 2009-08-05 | 2011-02-10 | Poniard Pharmaceuticals, Inc. | Stabilized picoplatin oral dosage form |
| CN101663040A (zh) * | 2007-02-09 | 2010-03-03 | 帕纳德制药公司 | 包封的吡铂 |
| WO2009037572A2 (en) * | 2007-06-04 | 2009-03-26 | Diagnoplex | Biomarker combinations for colorectal cancer |
| US20100260832A1 (en) * | 2007-06-27 | 2010-10-14 | Poniard Pharmaceuticals, Inc. | Combination therapy for ovarian cancer |
| TW200916094A (en) * | 2007-06-27 | 2009-04-16 | Poniard Pharmaceuticals Inc | Stabilized picoplatin dosage form |
| TW200920347A (en) * | 2007-07-16 | 2009-05-16 | Poniard Pharmaceuticals Inc | Oral formulations for picoplatin |
| US20110053879A1 (en) * | 2008-02-08 | 2011-03-03 | Poniard Pharmaceuticals, Inc. | Picoplatin and amrubicin to treat lung cancer |
| CZ306396B6 (cs) * | 2014-12-16 | 2017-01-04 | Vuab Pharma A.S. | Rozpustný platnatý komplex s pyridinkarboxamidinovým ligandem a způsob jeho přípravy |
| WO2022217255A1 (en) * | 2021-04-07 | 2022-10-13 | Klotho Therapeutics, Inc. | Novel antitumor compounds and related methods of manufacture and use |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4329299A (en) | 1979-08-23 | 1982-05-11 | Johnson, Matthey & Co., Limited | Composition of matter containing platinum |
| US4533502A (en) | 1983-02-22 | 1985-08-06 | Rochon Fernande D | Platinum (II) compounds and their preparation |
| EP0167310B1 (en) | 1984-06-27 | 1991-05-29 | Johnson Matthey Public Limited Company | Platinum co-ordination compounds |
| US4921963A (en) * | 1987-04-13 | 1990-05-01 | British Columbia Cancer Foundation | Platinum complexes with one radiosensitizing ligand |
| US5244919A (en) | 1988-02-02 | 1993-09-14 | Johnson Matthey, Inc. | Pt(IV) complexes as anti-tumor agents |
| GB9105037D0 (en) | 1991-03-09 | 1991-04-24 | Johnson Matthey Plc | Improvements in chemical compounds |
| US5624919A (en) * | 1993-09-14 | 1997-04-29 | The University Of Vermont And State Agricultural College | Trans platinum (IV) complexes |
| GB9502799D0 (en) | 1995-02-14 | 1995-04-05 | Johnson Matthey Plc | Improvements in platinum complexes |
| US5547982A (en) | 1995-02-27 | 1996-08-20 | Johnson Matthey, Inc. | Anti-tumor platinum complexes |
| EP1163247A1 (en) | 1999-03-19 | 2001-12-19 | Anormed Inc. | Pharmaceutical compositions comprising metal complexes |
| CN1250559C (zh) | 1999-04-13 | 2006-04-12 | 阿诺麦德股份有限公司 | 制备胺铂配合物的方法 |
-
2000
- 2000-10-04 US US09/678,595 patent/US6894049B1/en not_active Expired - Lifetime
-
2001
- 2001-10-02 KR KR1020037004780A patent/KR100864596B1/ko not_active Expired - Fee Related
- 2001-10-02 EP EP01975671A patent/EP1322654B1/en not_active Expired - Lifetime
- 2001-10-02 AU AU2001294969A patent/AU2001294969A1/en not_active Abandoned
- 2001-10-02 DE DE60137061T patent/DE60137061D1/de not_active Expired - Lifetime
- 2001-10-02 SI SI200130906T patent/SI1322654T1/sl unknown
- 2001-10-02 PT PT01975671T patent/PT1322654E/pt unknown
- 2001-10-02 AT AT01975671T patent/ATE417855T1/de active
- 2001-10-02 JP JP2002532453A patent/JP2004510778A/ja not_active Withdrawn
- 2001-10-02 ES ES01975671T patent/ES2319258T3/es not_active Expired - Lifetime
- 2001-10-02 WO PCT/US2001/030838 patent/WO2002028871A1/en not_active Ceased
- 2001-10-02 DK DK01975671T patent/DK1322654T3/da active
- 2001-10-03 AR ARP010104672A patent/AR032185A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE60137061D1 (de) | 2009-01-29 |
| EP1322654A1 (en) | 2003-07-02 |
| SI1322654T1 (sl) | 2009-06-30 |
| WO2002028871A1 (en) | 2002-04-11 |
| KR20030059174A (ko) | 2003-07-07 |
| EP1322654B1 (en) | 2008-12-17 |
| KR100864596B1 (ko) | 2008-10-22 |
| ATE417855T1 (de) | 2009-01-15 |
| PT1322654E (pt) | 2009-03-20 |
| JP2004510778A (ja) | 2004-04-08 |
| US6894049B1 (en) | 2005-05-17 |
| AU2001294969A1 (en) | 2002-04-15 |
| ES2319258T3 (es) | 2009-05-06 |
| DK1322654T3 (da) | 2009-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR032185A1 (es) | Complejos de cis-platino, utiles como agentes antitumorales, y las composiciones farmaceuticas que los contienen | |
| TR200102020T2 (tr) | Raf kinaz inhibitörleri olarak w-karboksiaril sübstitüe edilmiş difenil üreler. | |
| ES2053609T3 (es) | Derivados de urea inhibidores de lipoxigenasa. | |
| SE8800731L (sv) | Fenylkarbamat | |
| IL144026A0 (en) | Phenylphenanthridine derivatives and pharmaceutical compostions containing the same | |
| AR043084A1 (es) | Un metodo para preparar un complejo de cisplatino | |
| NO973059D0 (no) | Hydroxylaminderivater som er anvendbare for å höyne den molekylære chaperonproduksjon, og fremstilling derav | |
| TR200000023T2 (tr) | 3- ya da 4-eşlenimli 4-(aminometil)-piperidin türevlerinin iki halkalı gastrokinetik benzamidleri. | |
| ECSP055582A (es) | Derivados de benzotiazol que tienen actividad agonista de beta-2-adrenorreceptor | |
| NO20060973L (no) | Pyridylderivater og deres anvendelse som tempeutiske midler | |
| BR9812218A (pt) | Novos derivativos de taxane | |
| KR960004344A (ko) | 6원 질소 함유 헤테로아릴-옥사졸리디논 | |
| ES2157399T3 (es) | Complejos de platino. | |
| AR044650A1 (es) | Derivados de tiofeno - pirimidinona y su uso en la terapia de enfermedades que requieren la inhibicion de la enzima 17b-hidroxiesteroide-dehidrogenasa. | |
| ES2093237T3 (es) | Derivados de hidrazina farmacologicamente activos y procedimiento para su obtencion. | |
| NO20021859D0 (no) | Nye digosakkarider, deres fremstilling samt farmasöytiske preparater | |
| DE69928660D1 (de) | Verwendung von vitamin pp verbindungen | |
| ES2058504T3 (es) | Derivados de piperidina y piperazina, procedimiento para preparar los mismos, y composiciones farmaceuticas que contienen los mismos. | |
| ES2089687T3 (es) | 4-fenil-piridonas y 4-fenil-2-alcoxipiridinas sustituidas como inhibidores de la hmg-coa-reductasa. | |
| EA200200096A1 (ru) | Новые производные витамина d с циклическими субструктурами в боковых цепях, способ и промежуточные продукты для их получения и их применение для получения лекарственных средств | |
| ES2109993T3 (es) | Derivados de 4-desoxi-4-epipodofilotoxina o sus sales farmaceuticamente aceptables. | |
| FR2354761A1 (fr) | Acides n-aryl-anthraniliques, leurs procedes de preparation et compositions pharmaceutiques contenant lesdits acides anthraniliques | |
| PT1095040E (pt) | Novos benzoxazoles com actividade inibidora da pde | |
| DE60117248D1 (de) | Parenterale lösung enthaltend amiodaron | |
| EP1044971A4 (en) | TAXAN DERIVATIVES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |